Hypoxia-Triggered Nanoscale Metal-Organic Frameworks for Enhanced Anticancer Activity

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Photodynamic therapy (PDT) effectiveness is limited by tumor hypoxia.
• Hypoxia can activate specific prodrugs, suggesting combined therapy potential.
• Nanoscale metal-organic frameworks (NMOFs) offer platforms for drug delivery and therapy.

Purpose of the Study:

• To develop a multifunctional NMOF platform for combined PDT and hypoxia-activated chemotherapy.
• To enhance reactive oxygen species (ROS) generation for PDT.
• To improve the loading and release of hypoxia-activated prodrugs for synergistic effects.

Main Methods:

• Synthesis of a Hf-porphyrin NMOF (Hf-TCPP) with high porphyrin loading.
• Loading of the hypoxia-activated prodrug tirapazamine (TPZ) onto the Hf-TCPP platform.
• Surface modification with a dopamine-derived polymer (DOPA-PIMA-mPEG) for improved stability and drug release.
• Evaluation of ROS generation for PDT and TPZ activation under hypoxic conditions.

Main Results:

• Hf-TCPP nanoparticles demonstrated high TCPP content (>50 wt %) and efficient ROS generation.
• The NMOF platform achieved high loading of TPZ and controlled release kinetics.
• The combined therapy approach showed enhanced antitumor efficacy by leveraging hypoxia.

Conclusions:

• The developed NMOF platform effectively combines PDT and hypoxia-activated chemotherapy.
• This strategy overcomes PDT limitations in hypoxic tumors and enhances therapeutic outcomes.
• NMOF-based platforms show significant promise for advanced antitumor therapies.